Search Results for "Lysteda"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Lysteda. Results 1 to 1 of 1 total matches.
See also: tranexamic acid

Myfembree for Fibroid-Associated Heavy Menstrual Bleeding

   
The Medical Letter on Drugs and Therapeutics • Aug 09, 2021  (Issue 1630)
contraceptives, oral tranexamic acid (Lysteda, and generics), and oral nonsteroidal antiinflammatory drugs ...
Myfembree (Myovant/Pfizer), an oral fixed-dose combination of the gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix, the estrogen estradiol, and the progestin norethindrone acetate, has been approved by the FDA for management of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women. It is the second product to be approved in the US for this indication; Oriahnn, which contains the GnRH receptor antagonist elagolix in combination with estradiol and norethindrone acetate, was approved earlier. Relugolix was approved for...
Med Lett Drugs Ther. 2021 Aug 9;63(1630):121-3 |  Show IntroductionHide Introduction